Keywords: ViiV Healthcare, laxoSmithKline, Pfizer, Celsentri, Selzentry, Once-daily, USA, Europe

ViiV Healthcare withdraws applications of once-daily Celsentri/Selzentry

Article | 21 September 2011

UK-based ViiV Healthcare, a global specialist HIV company established in November 2009 by UK pharma giant GlaxoSmithKline (NYSE: GSK), which holds ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

GlaxoSmithKline

ViiV Healthcare

Pfizer

Go to company listing

Related Drugs

Selzentry

Celsentri

Go to drug listing